clinical trial · NCT07030959
Study of AUBE00 in Patients With Solid Tumors
Solid TumorsAUBE00Cetuximab
brief summary
This is a first-in-human, Phase I, open-label, multicenter, multinational study, designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and anti-tumor activity of AUBE00 in patients with locally advanced or metastatic solid tumors.The total number of patients in this study will be approximately 90 to 130.
started
Jun 5, 2025
primary completion
Dec 31, 2029
completion
Dec 31, 2029
last updated
Feb 25, 2026
official title
A Phase I Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Activity of AUBE00 in Patients With Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol